Contact
searchSearch
HMP Global

Pediatric Dermatology Topic Center

Featured

FDA Alerts
FDA Approves Vyjuvek for Treatment of Wounds in Patients with Dystrophic Epidermolysis Bullosa
08/10/2023
Jessica Garlewicz
The US Food and Drug Administration recently announced approval of VYJUVEK (beremagene geperpavec [B-VEC]) for the treatment of wounds in patients ages 6 months and older with dystrophic epidermolysis bullosa.
The US Food and Drug Administration recently announced approval of VYJUVEK (beremagene geperpavec [B-VEC]) for the treatment of wounds in patients ages 6 months and older with dystrophic epidermolysis bullosa.
The US Food and Drug...
08/10/2023
The Dermatologist
News
Patients With Pediatric Granuloma Annulare Often Present With Asthma and Atopy
01/31/2023
Lisa Kuhns, PhD, MD
Researchers aimed to perform a clinical and histopathologic evaluation of 41 pediatric GA cases in a retrospective study.
Researchers aimed to perform a clinical and histopathologic evaluation of 41 pediatric GA cases in a retrospective study.
Researchers aimed to perform a...
01/31/2023
The Dermatologist
CH
Videos
How to Teach Families About Safe Hair Care for Skin of Color
01/17/2022
Candrice Heath, MD, FAAP, FAAD
Candrice Heath, MD, discusses how to teach families about safe hair care practices for skin of color.
Candrice Heath, MD, discusses how to teach families about safe hair care practices for skin of color.
Candrice Heath, MD, discusses...
01/17/2022
The Dermatologist
CH
Videos
Integrating Skin of Color Hair Care for Young Patients
01/09/2022
Candrice Heath, MD, FAAP, FAAD
In this video, Candrice Heath, MD, shares what dermatologists should consider when treating skin of color hair in younger patients.
In this video, Candrice Heath, MD, shares what dermatologists should consider when treating skin of color hair in younger patients.
In this video, Candrice Heath,...
01/09/2022
The Dermatologist
News
Tobacco Exposure Linked to Childhood Psoriasis
12/23/2021
Lauren Mateja
A study in Pediatric Dermatology found that environmental tobacco smoke exposure at home was associated with childhood psoriasis in a Turkish population study.
A study in Pediatric Dermatology found that environmental tobacco smoke exposure at home was associated with childhood psoriasis in a Turkish population study.
A study in Pediatric Dermatology...
12/23/2021
The Dermatologist
News
Paraben Exposure Increases Atopic Dermatitis Prevalence in Young Children
12/18/2021
Lisa Kuhns, PhD, MD
High exposure to parabens in children aged 0 to 3 years increased the prevalence of atopic dermatitis (AD), according to a recent study from Japan.
High exposure to parabens in children aged 0 to 3 years increased the prevalence of atopic dermatitis (AD), according to a recent study from Japan.
High exposure to parabens in...
12/18/2021
The Dermatologist
News
Atopic Dermatitis Associated With Shorter Stature and Higher BMI in Children
12/13/2021
Lisa Kuhns, PhD, MD
Atopic dermatitis in children is associated with shorter stature, higher BMI, and lower weight in early childhood, but these associations resolve with age.
Atopic dermatitis in children is associated with shorter stature, higher BMI, and lower weight in early childhood, but these associations resolve with age.
Atopic dermatitis in children is...
12/13/2021
The Dermatologist
News
Pediatric Urticaria Resolution Associated With Elevated CD63 Levels and Thyroid Comorbidity
04/13/2021
Elevated CD63 levels and thyroid disease are associated with chronic inducible urticaria (CIndU) resolution in pediatric patients.
Elevated CD63 levels and thyroid disease are associated with chronic inducible urticaria (CIndU) resolution in pediatric patients.
Elevated CD63 levels and thyroid...
04/13/2021
The Dermatologist
News
Metabolic Syndrome and Insulin Resistance Found in Pre-Pubertal Children With Psoriasis
01/29/2021
A high prevalence of metabolic syndrome (MetS) and insulin resistance exists in pre-pubertal children with psoriasis, according to a recent publication in the European Journal of Pediatrics.
A high prevalence of metabolic syndrome (MetS) and insulin resistance exists in pre-pubertal children with psoriasis, according to a recent publication in the European Journal of Pediatrics.
A high prevalence of metabolic...
01/29/2021
The Dermatologist
News
Itch NRS Suitable for Pediatric Psoriasis Population
01/04/2021
Use of the Itch Numeric Rating Scale (NRS) in adults with psoriasis is common, but standard use in a similar pediatric population has not been established. A qualitative study supports the content validity of the Itch NRS for pediatric...
Use of the Itch Numeric Rating Scale (NRS) in adults with psoriasis is common, but standard use in a similar pediatric population has not been established. A qualitative study supports the content validity of the Itch NRS for pediatric...
Use of the Itch Numeric Rating...
01/04/2021
The Dermatologist
Q&As
Amplifying the Voice of Women in Pediatric Dermatology
12/14/2020
Lauren Mateja
Women have found an increasing presence throughout dermatology both at a general and subspecialty level, but gaps in representation remain.  Over the past decade, women have found a growing role in the...
Women have found an increasing presence throughout dermatology both at a general and subspecialty level, but gaps in representation remain.  Over the past decade, women have found a growing role in the...
...
12/14/2020
The Dermatologist

Expert Insights

CH
Videos
How to Teach Families About Safe Hair Care for Skin of Color
01/17/2022
Candrice Heath, MD, FAAP, FAAD
Candrice Heath, MD, discusses how to teach families about safe hair care practices for skin of color.
Candrice Heath, MD, discusses how to teach families about safe hair care practices for skin of color.
Candrice Heath, MD, discusses...
01/17/2022
The Dermatologist
CH
Videos
Integrating Skin of Color Hair Care for Young Patients
01/09/2022
Candrice Heath, MD, FAAP, FAAD
In this video, Candrice Heath, MD, shares what dermatologists should consider when treating skin of color hair in younger patients.
In this video, Candrice Heath, MD, shares what dermatologists should consider when treating skin of color hair in younger patients.
In this video, Candrice Heath,...
01/09/2022
The Dermatologist
Q&As
Amplifying the Voice of Women in Pediatric Dermatology
12/14/2020
Lauren Mateja
Women have found an increasing presence throughout dermatology both at a general and subspecialty level, but gaps in representation remain.  Over the past decade, women have found a growing role in the...
Women have found an increasing presence throughout dermatology both at a general and subspecialty level, but gaps in representation remain.  Over the past decade, women have found a growing role in the...
...
12/14/2020
The Dermatologist
eee
Podcasts
Dr Heath Shares Clinical Pearls for Treating Pediatric Patients
10/02/2020
Candrice Heath, MD, shared her insights on treating pediatric patients, and why it is important for all dermatologists, including those who only see adults, to learn about treating younger patients.
Candrice Heath, MD, shared her insights on treating pediatric patients, and why it is important for all dermatologists, including those who only see adults, to learn about treating younger patients.
Candrice Heath, MD, shared her...
10/02/2020
The Dermatologist
Cover Story
More to Skin Than Meets the Eye: Bullying and Childhood Skin Conditions
09/11/2020
Sasha D. Jaquez, PhD; Maria A. Leszczynska, MD
Bullying is common in childhood, and children with visible skin conditions can be highly vulnerable. Dermatologists can play a critical role into helping their pediatric patients through early screening and management.
Bullying is common in childhood, and children with visible skin conditions can be highly vulnerable. Dermatologists can play a critical role into helping their pediatric patients through early screening and management.
Bullying is common in childhood,...
09/11/2020
The Dermatologist
Feature Story
Treating Molluscum Contagiosum: Current Choices vs the Future Pipeline
02/13/2020
Without approved treatment options for molluscum contagiosum, doctors have differing opinions on how and even whether to treat. Recent interviews with dermatologists and pediatricians offer insight into the treatments that these two...
Without approved treatment options for molluscum contagiosum, doctors have differing opinions on how and even whether to treat. Recent interviews with dermatologists and pediatricians offer insight into the treatments that these two...
Without approved treatment...
02/13/2020
The Dermatologist
Melissa Piliang
Videos
Managing Eyebrow & Eyelash Loss in Alopecia Areata: Emotional Impact & Treatment Insights
02/01/2026
Melissa Piliang, MD
In an insightful conversation with Dr Melissa Piliang, we explore how eyebrow and eyelash loss affects patients’ quality of life, advancements in treatment options, and how new clinical trials are offering hope for patients seeking eyebrow...
In an insightful conversation with Dr Melissa Piliang, we explore how eyebrow and eyelash loss affects patients’ quality of life, advancements in treatment options, and how new clinical trials are offering hope for patients seeking eyebrow...
In an insightful conversation...
02/01/2026
The Dermatologist
Cover Story
Forward Focus: Top Trends in Dermatology for 2026
01/30/2026
Joseph F. Merola, MD, MMSc; Alice Bendix Gottlieb, MD, PhD
From low disease activity and remission to digital measurement, equity, and access, Dr Joseph Merola and Dr Alice Gottlieb map where dermatology is heading next.
From low disease activity and remission to digital measurement, equity, and access, Dr Joseph Merola and Dr Alice Gottlieb map where dermatology is heading next.
From low disease activity and...
01/30/2026
The Dermatologist
Peter Lio
Clinical Insights
Urbanization, Lifestyle, and Skin Barrier Damage in Atopic Dermatitis
01/20/2026
Peter Lio, MD, FAAD
Dr Peter Lio discusses how urbanization, modern lifestyles, and shifting environmental exposures may be driving rising rates of allergic rhinitis, food allergy, and atopic dermatitis—and which exposures should most concern clinicians.
Dr Peter Lio discusses how urbanization, modern lifestyles, and shifting environmental exposures may be driving rising rates of allergic rhinitis, food allergy, and atopic dermatitis—and which exposures should most concern clinicians.
Dr Peter Lio discusses how...
01/20/2026
Allergy & Immunology
Stephen D. Hess, MD, PhD
Videos
Electrical Impedance Spectroscopy For Skin Cancer Screening
01/13/2026
Stephen D. Hess, MD, PhD
Dr Stephen Hess shares how he integrates the augmented intelligence-based Nevisense device into real-world dermatology practice to enhance clinical decision-making.
Dr Stephen Hess shares how he integrates the augmented intelligence-based Nevisense device into real-world dermatology practice to enhance clinical decision-making.
Dr Stephen Hess shares how he...
01/13/2026
The Dermatologist
melissa Piliang
Videos
JAK Inhibitors & Boxed Warnings
12/17/2025
Melissa Piliang, MD
Gain expert insight into the origins and implications of the boxed warning on JAK inhibitors for dermatologists treating alopecia areata. Learn about clinical trial data, patient selection, risk mitigation strategies, and the importance of...
Gain expert insight into the origins and implications of the boxed warning on JAK inhibitors for dermatologists treating alopecia areata. Learn about clinical trial data, patient selection, risk mitigation strategies, and the importance of...
Gain expert insight into the...
12/17/2025
The Dermatologist
Cover Story
Redefining the Standard: Adjuvant and Neoadjuvant Immunotherapy in High-Risk, Advanced CSCC
12/09/2025
Vishal A Patel, MD
With new data supporting adjuvant cemiplimab and promising outcomes from neoadjuvant strategies, immunotherapy is reshaping the treatment landscape for high-risk and advanced cutaneous squamous cell carcinoma.
With new data supporting adjuvant cemiplimab and promising outcomes from neoadjuvant strategies, immunotherapy is reshaping the treatment landscape for high-risk and advanced cutaneous squamous cell carcinoma.
With new data supporting...
12/09/2025
The Dermatologist
Part 3
Videos
Part 3: Rebuilding Confidence: Multidisciplinary and Holistic Approaches to Severe Alopecia Areata
11/03/2025
Brittany Craiglow, MD; Brett A. King, MD, PhD; Maryanne Makredes Senna, MD
In the final installment of this expert roundtable series, top dermatologists discuss holistic care in alopecia areata, including emotional support, patient education, and resources like the National Alopecia Areata Foundation. Learn how to...
In the final installment of this expert roundtable series, top dermatologists discuss holistic care in alopecia areata, including emotional support, patient education, and resources like the National Alopecia Areata Foundation. Learn how to...
In the final installment of this...
11/03/2025
The Dermatologist
Part 3
Q&As
Rebuilding Confidence in Alopecia Areata: Multidisciplinary, Holistic Support for Patients and Families
11/03/2025
Brittany Craiglow, MD; Brett A. King, MD, PhD; Maryanne Makredes Senna, MD
Experts explore holistic and emotional support strategies to empower patients with alopecia areata—beyond medicine, toward identity and healing.
Experts explore holistic and emotional support strategies to empower patients with alopecia areata—beyond medicine, toward identity and healing.
Experts explore holistic and...
11/03/2025
The Dermatologist
Cover Story
Chronic Hand Eczema: Breaking Out of the Atopic Dermatitis Umbrella
10/06/2025
Jeff Yu, MD
This condition may be far more common and burdensome than previously recognized in US dermatologic practice.
This condition may be far more common and burdensome than previously recognized in US dermatologic practice.
This condition may be far more...
10/06/2025
The Dermatologist
Feature Story
Monitoring Patients on Systemic Treatments: Deucravacitinib
10/06/2025
Dina Collins, MD, MS; Chenan Andy Huang, MD; Kristina Callis-Duffin, MD, MS; Shari Lipner, MD, PhD; Bruce E. Strober, MD, PhD; Steven R. Feldman, MD, PhD
This new series presents practical, concise guidance for monitoring specific systemic drugs. In this article, dermatologists share their approach to the oral Janus kinase inhibitor deucravacitinib for patients with moderate-to-severe plaque...
This new series presents practical, concise guidance for monitoring specific systemic drugs. In this article, dermatologists share their approach to the oral Janus kinase inhibitor deucravacitinib for patients with moderate-to-severe plaque...
This new series presents...
10/06/2025
The Dermatologist

News and Quizzes

FDA Alerts
FDA Approves Vyjuvek for Treatment of Wounds in Patients with Dystrophic Epidermolysis Bullosa
08/10/2023
Jessica Garlewicz
The US Food and Drug Administration recently announced approval of VYJUVEK (beremagene geperpavec [B-VEC]) for the treatment of wounds in patients ages 6 months and older with dystrophic epidermolysis bullosa.
The US Food and Drug Administration recently announced approval of VYJUVEK (beremagene geperpavec [B-VEC]) for the treatment of wounds in patients ages 6 months and older with dystrophic epidermolysis bullosa.
The US Food and Drug...
08/10/2023
The Dermatologist
News
Patients With Pediatric Granuloma Annulare Often Present With Asthma and Atopy
01/31/2023
Lisa Kuhns, PhD, MD
Researchers aimed to perform a clinical and histopathologic evaluation of 41 pediatric GA cases in a retrospective study.
Researchers aimed to perform a clinical and histopathologic evaluation of 41 pediatric GA cases in a retrospective study.
Researchers aimed to perform a...
01/31/2023
The Dermatologist
News
Tobacco Exposure Linked to Childhood Psoriasis
12/23/2021
Lauren Mateja
A study in Pediatric Dermatology found that environmental tobacco smoke exposure at home was associated with childhood psoriasis in a Turkish population study.
A study in Pediatric Dermatology found that environmental tobacco smoke exposure at home was associated with childhood psoriasis in a Turkish population study.
A study in Pediatric Dermatology...
12/23/2021
The Dermatologist
News
Paraben Exposure Increases Atopic Dermatitis Prevalence in Young Children
12/18/2021
Lisa Kuhns, PhD, MD
High exposure to parabens in children aged 0 to 3 years increased the prevalence of atopic dermatitis (AD), according to a recent study from Japan.
High exposure to parabens in children aged 0 to 3 years increased the prevalence of atopic dermatitis (AD), according to a recent study from Japan.
High exposure to parabens in...
12/18/2021
The Dermatologist
News
Atopic Dermatitis Associated With Shorter Stature and Higher BMI in Children
12/13/2021
Lisa Kuhns, PhD, MD
Atopic dermatitis in children is associated with shorter stature, higher BMI, and lower weight in early childhood, but these associations resolve with age.
Atopic dermatitis in children is associated with shorter stature, higher BMI, and lower weight in early childhood, but these associations resolve with age.
Atopic dermatitis in children is...
12/13/2021
The Dermatologist
News
Pediatric Urticaria Resolution Associated With Elevated CD63 Levels and Thyroid Comorbidity
04/13/2021
Elevated CD63 levels and thyroid disease are associated with chronic inducible urticaria (CIndU) resolution in pediatric patients.
Elevated CD63 levels and thyroid disease are associated with chronic inducible urticaria (CIndU) resolution in pediatric patients.
Elevated CD63 levels and thyroid...
04/13/2021
The Dermatologist
psoriasis
News
Low Prevalence but Meaningful Impact of Psychological Symptoms Seen in Well-Controlled Psoriasis
02/03/2026
Jessica Garlewicz
Anxiety and depression symptoms can still occur in young adults with well-controlled psoriasis, even when disease activity is minimal, according to a cross-sectional study exploring psychological distress and its potential biological...
Anxiety and depression symptoms can still occur in young adults with well-controlled psoriasis, even when disease activity is minimal, according to a cross-sectional study exploring psychological distress and its potential biological...
Anxiety and depression symptoms...
02/03/2026
The Dermatologist
psoriasis
News
Mathematical Modeling Study Highlights Cytokine Balance and Stem Cell Feedback in Psoriasis Control
01/22/2026
Jessica Garlewicz
A new systems biology study using mathematical modeling provides insight into how cytokine imbalance drives psoriasis flares and suggests that restoring immune-epidermal feedback.
A new systems biology study using mathematical modeling provides insight into how cytokine imbalance drives psoriasis flares and suggests that restoring immune-epidermal feedback.
A new systems biology study...
01/22/2026
The Dermatologist
Quiz
Initiating JAK Inhibitors in AA: Screening, Safety, and Shared Decision-Making
01/15/2026
Riya Gandhi, MA
Test your knowledge of best practices before initiating JAK inhibitors for alopecia areata.
Test your knowledge of best practices before initiating JAK inhibitors for alopecia areata.
Test your knowledge of best...
01/15/2026
The Dermatologist
Cutaneous Squamous Cell Carcinoma
News
Managing Cutaneous Squamous Cell Carcinoma
01/06/2026
Jessica Garlewicz
An updated evidence-based review outlines contemporary strategies for evaluating and managing cutaneous squamous cell carcinoma.
An updated evidence-based review outlines contemporary strategies for evaluating and managing cutaneous squamous cell carcinoma.
An updated evidence-based review...
01/06/2026
The Dermatologist
Quiz
MACE Risk in Alopecia Areata: What Clinical Trials and Real-World Data Reveal
01/05/2026
Riya Gandhi, MA
This quiz examines which patients experienced MACE events in clinical trials and how real-world incidence data compares.
This quiz examines which patients experienced MACE events in clinical trials and how real-world incidence data compares.
This quiz examines which...
01/05/2026
The Dermatologist
Quiz
Why Higher JAK Doses Raise Safety Concerns in AD
01/01/2026
Riya Gandhi, MA
Dive into kinase dynamics—can you pinpoint the molecular reason behind increased adverse event risk with high-dose JAK inhibitor therapy?
Dive into kinase dynamics—can you pinpoint the molecular reason behind increased adverse event risk with high-dose JAK inhibitor therapy?
Dive into kinase dynamics—can...
01/01/2026
The Dermatologist
Quiz
What Drives Fibrosis in Chronic Atopic Dermatitis Lesions?
01/01/2026
Riya Gandhi, MA
Take the quiz to explore how fibroblasts respond to Type 2 cytokines in long-standing AD.
Take the quiz to explore how fibroblasts respond to Type 2 cytokines in long-standing AD.
Take the quiz to explore how...
01/01/2026
The Dermatologist
Quiz
Alopecia Areata Support Systems, Peer Networks, and Patient Misinformation
12/20/2025
Riya Gandhi, MA
How do you guide patients through peer-driven misinformation and anxiety-provoking online forums? Take this quiz to refine your approach to trusted resources and patient-centered reassurance.
How do you guide patients through peer-driven misinformation and anxiety-provoking online forums? Take this quiz to refine your approach to trusted resources and patient-centered reassurance.
How do you guide patients...
12/20/2025
The Dermatologist
acne
Quiz
Quiz: Acne Topical Therapy
12/18/2025
Jessica Garlewicz
Which advancement in topical acne therapy was highlighted as improving tolerability while maintaining efficacy?
Which advancement in topical acne therapy was highlighted as improving tolerability while maintaining efficacy?
Which advancement in topical...
12/18/2025
The Dermatologist
psoriasis
Quiz
Quiz: Clinical Clue in Psoriasis Diagnosis
12/18/2025
Jessica Garlewicz
What clinical clue should prompt a dermatologist to question the diagnosis of psoriasis, especially when highly effective agents fail?
What clinical clue should prompt a dermatologist to question the diagnosis of psoriasis, especially when highly effective agents fail?
What clinical clue should prompt...
12/18/2025
The Dermatologist
jan/feb issue

Current Issue

January 2026
Volume 34
Issue 1
Current Issue
Issue Archive
The Dermatologist Newsletter

Recent News

FDA Alerts
FDA Approves Vyjuvek for Treatment of Wounds in Patients with Dystrophic Epidermolysis Bullosa
08/10/2023
Jessica Garlewicz
The US Food and Drug Administration recently announced approval of VYJUVEK (beremagene geperpavec [B-VEC]) for the treatment of wounds in patients ages 6 months and older with dystrophic epidermolysis bullosa.
The US Food and Drug Administration recently announced approval of VYJUVEK (beremagene geperpavec [B-VEC]) for the treatment of wounds in patients ages 6 months and older with dystrophic epidermolysis bullosa.
The US Food and Drug...
08/10/2023
The Dermatologist
News
Patients With Pediatric Granuloma Annulare Often Present With Asthma and Atopy
01/31/2023
Lisa Kuhns, PhD, MD
Researchers aimed to perform a clinical and histopathologic evaluation of 41 pediatric GA cases in a retrospective study.
Researchers aimed to perform a clinical and histopathologic evaluation of 41 pediatric GA cases in a retrospective study.
Researchers aimed to perform a...
01/31/2023
The Dermatologist
News
Tobacco Exposure Linked to Childhood Psoriasis
12/23/2021
Lauren Mateja
A study in Pediatric Dermatology found that environmental tobacco smoke exposure at home was associated with childhood psoriasis in a Turkish population study.
A study in Pediatric Dermatology found that environmental tobacco smoke exposure at home was associated with childhood psoriasis in a Turkish population study.
A study in Pediatric Dermatology...
12/23/2021
The Dermatologist
News
Paraben Exposure Increases Atopic Dermatitis Prevalence in Young Children
12/18/2021
Lisa Kuhns, PhD, MD
High exposure to parabens in children aged 0 to 3 years increased the prevalence of atopic dermatitis (AD), according to a recent study from Japan.
High exposure to parabens in children aged 0 to 3 years increased the prevalence of atopic dermatitis (AD), according to a recent study from Japan.
High exposure to parabens in...
12/18/2021
The Dermatologist
News
Atopic Dermatitis Associated With Shorter Stature and Higher BMI in Children
12/13/2021
Lisa Kuhns, PhD, MD
Atopic dermatitis in children is associated with shorter stature, higher BMI, and lower weight in early childhood, but these associations resolve with age.
Atopic dermatitis in children is associated with shorter stature, higher BMI, and lower weight in early childhood, but these associations resolve with age.
Atopic dermatitis in children is...
12/13/2021
The Dermatologist
News
Pediatric Urticaria Resolution Associated With Elevated CD63 Levels and Thyroid Comorbidity
04/13/2021
Elevated CD63 levels and thyroid disease are associated with chronic inducible urticaria (CIndU) resolution in pediatric patients.
Elevated CD63 levels and thyroid disease are associated with chronic inducible urticaria (CIndU) resolution in pediatric patients.
Elevated CD63 levels and thyroid...
04/13/2021
The Dermatologist
psoriasis
News
Low Prevalence but Meaningful Impact of Psychological Symptoms Seen in Well-Controlled Psoriasis
02/03/2026
Jessica Garlewicz
Anxiety and depression symptoms can still occur in young adults with well-controlled psoriasis, even when disease activity is minimal, according to a cross-sectional study exploring psychological distress and its potential biological...
Anxiety and depression symptoms can still occur in young adults with well-controlled psoriasis, even when disease activity is minimal, according to a cross-sectional study exploring psychological distress and its potential biological...
Anxiety and depression symptoms...
02/03/2026
The Dermatologist
psoriasis
News
Mathematical Modeling Study Highlights Cytokine Balance and Stem Cell Feedback in Psoriasis Control
01/22/2026
Jessica Garlewicz
A new systems biology study using mathematical modeling provides insight into how cytokine imbalance drives psoriasis flares and suggests that restoring immune-epidermal feedback.
A new systems biology study using mathematical modeling provides insight into how cytokine imbalance drives psoriasis flares and suggests that restoring immune-epidermal feedback.
A new systems biology study...
01/22/2026
The Dermatologist
Cutaneous Squamous Cell Carcinoma
News
Managing Cutaneous Squamous Cell Carcinoma
01/06/2026
Jessica Garlewicz
An updated evidence-based review outlines contemporary strategies for evaluating and managing cutaneous squamous cell carcinoma.
An updated evidence-based review outlines contemporary strategies for evaluating and managing cutaneous squamous cell carcinoma.
An updated evidence-based review...
01/06/2026
The Dermatologist
Atopic dermatitis
FDA Alerts
FDA Approves Roflumilast Cream 0.05% for Treatment of Atopic Dermatitis in Children Aged 2 to 5
10/06/2025
Riya Gandhi, MA
On October 6, 2025, the US FDA approved ZORYVE (roflumilast) cream 0.05% for the topical treatment of mild-to-moderate atopic dermatitis in pediatric patients aged 2 to 5 years.
On October 6, 2025, the US FDA approved ZORYVE (roflumilast) cream 0.05% for the topical treatment of mild-to-moderate atopic dermatitis in pediatric patients aged 2 to 5 years.
On October 6, 2025, the US FDA...
10/06/2025
The Dermatologist
AD
FDA Alerts
FDA Approves Opzelura for Atopic Dermatitis in Children Aged 2–11
09/18/2025
Riya Gandhi, MA
US FDA approved Opzelura (ruxolitinib) cream 1.5% for the short-term and noncontinuous chronic treatment of mild-to-moderate AD in nonimmunocompromised children aged 2 years and older.
US FDA approved Opzelura (ruxolitinib) cream 1.5% for the short-term and noncontinuous chronic treatment of mild-to-moderate AD in nonimmunocompromised children aged 2 years and older.
US FDA approved Opzelura...
09/18/2025
The Dermatologist
FDA Alerts
Anzupgo Available for Prescribing Today
09/08/2025
Coleen Stern, MA
FDA recently approved delgocitinib cream as the first and only treatment indicated for moderate-to-severe chronic hand eczema in adults.
FDA recently approved delgocitinib cream as the first and only treatment indicated for moderate-to-severe chronic hand eczema in adults.
FDA recently approved...
09/08/2025
The Dermatologist
psoriatic arthritis
News
Rare Case Highlights Diagnostic and Treatment Challenges in PsA–Myopathy Overlap
09/02/2025
Jessica Garlewicz
The case study, accompanied by a review of 17 similar reports, details shared immunopathogenesis and conflicting treatment responses in this rare overlap syndrome.
The case study, accompanied by a review of 17 similar reports, details shared immunopathogenesis and conflicting treatment responses in this rare overlap syndrome.
The case study, accompanied by a...
09/02/2025
The Dermatologist
psoriatic arthritis
News
Real-World Data Support ITABIO Guidelines for Second-Line Biologic Use in Inflammatory Arthritis
09/02/2025
Jessica Garlewicz
The study evaluated treatment patterns and patient characteristics to assess the impact of these guidelines in real-world care.
The study evaluated treatment patterns and patient characteristics to assess the impact of these guidelines in real-world care.
The study evaluated treatment...
09/02/2025
The Dermatologist
psoriasis
News
Study Links Hypothyroidism to Psoriasis, Independent of Disease Severity
09/02/2025
Jessica Garlewicz
The findings suggest that thyroid abnormalities may represent an independent comorbidity, rather than a direct consequence of psoriasis severity.
The findings suggest that thyroid abnormalities may represent an independent comorbidity, rather than a direct consequence of psoriasis severity.
The findings suggest that...
09/02/2025
The Dermatologist
psoriasis
News
Beta-Blockers Not Linked to Increased Psoriasis Risk, Study Finds
09/02/2025
Jessica Garlewicz
A new multi-method analysis challenges long-standing concerns regarding beta-blockers and their role in triggering or worsening psoriasis.
A new multi-method analysis challenges long-standing concerns regarding beta-blockers and their role in triggering or worsening psoriasis.
A new multi-method analysis...
09/02/2025
The Dermatologist

HMP Global Products

Events

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2026 HMP Global. All Rights Reserved.
Cookie Policy Privacy Policy Terms of Use